Industries > Pharma > World Cancer-Treating Drugs Market Forecast 2017-2027

World Cancer-Treating Drugs Market Forecast 2017-2027

Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs

PUBLISHED: 14 September 2017
PAGES: 146
PRODUCT CODE: PHA0236

Clear
WOOCS 2.2.1
SKU: PHA0236 Categories: , , Tag:

The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached $102bn in 2016, dominated by the immunotherapy segment which held 44.1% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 194-page report you will receive 110 tables and 101 figures – all unavailable elsewhere.

The 194-page report provides clear detailed insight into the world cancer-treating drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

World cancer-treating drugs market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the world cancer-treating drugs market by its leading segments:
– Immunotherapy
– Chemotherapy
– Targeted Therapy
– Hormone Therapy

Each sector is analysed and revenue forecasts presented.

• This report discusses and forecasts revenues of the top 25 anti-cancer drugs:
– Avastin
– Herceptin
– Rituxan
– Gleevec
– Revlimid
– Alimta
– Velcade
– Erbitux
– Gardasil
– Zytiga
– Xeloda
– Tarceva
– Afinitor
– Sprycel
– Tasigna
– Sutent
– Nexavar
– Xgeva
– Zoladex
– Yervoy
– Vidaza
– Treanda
– Temodar
– Faslodex
– Abraxane
– Others

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America: US, Canada, Mexico
– South America: Brazil, Argentina, Paraguay, Brazil, Rest of South America
– Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
– Rest of World: Middle East, Africa, Other Countries

• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the cancer-treating drugs market

World Cancer-Treating Drugs Market Forecast 2017-2027

• Our study discusses the selected leading companies that are the major players in the cancer-treating drugs market:
– AstraZeneca
– Merck & Co., Inc. (Merck)
– Novartis
– Amgen
– Bristol-Myers Squibb (BMS)
– GlaxoSmithKline (GSK)
– Johnson & Johnson (J&J)
– Roche
– Eli Lilly
– Celgene

The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.

Visiongain’s study is intended for anyone requiring commercial analyses for the world cancer-treating drugs market. You find data, trends and predictions.

Buy our report today World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for World Cancer-Treating Drugs Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for World Cancer-Treating Drugs Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories